Approval · Notice of Compliance 4977 · 1995
ZYRTEC: Notice of Compliance 4977
Issued February 1, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4977
- Date
- February 1, 1995
- Company
- Ucb Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Histamine h1 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYRTEC | 02145782 | — |
| ZYRTEC | 02145790 | Cancelled Post Market |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 5 MG per TAB
- CETIRIZINE HYDROCHLORIDE 10 MG per TAB